Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine vs. Norepinephrine in Neonates With PPHN and Hypotension
NCT07322133Phase 4Recruiting
- Sponsor
- University of California, Davis
- Start
- Oct 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 4 trial of dopamine, norepinephrine in hypotension, persistent pulmonary hypertension of the newborn (PPHN), hypoxemic respiratory failure, sponsored by University of California, Davis. Started Oct 2026; status: recruiting.
02
Drugs
dopaminenorepinephrine
03
Conditions
hypotensionpersistent pulmonary hypertension of the newborn (PPHN)hypoxemic respiratory failure
Beyond the preview
Go deeper on NCT07322133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07322133.